Amoxyclavim

# Amoxyclavim ## Overview - **Classification**: Penicillin antibiotic, Beta-lactamase inhibitor combination - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis. Clavulanate protects amoxicillin from degradation by irreversibly binding to beta-lactamase enzymes. ## Primary Indications 1. **Acute Bacterial Sinusitis**: Infection of the paranasal sinuses. 2. **Acute Otitis Media (AOM)**: Middle ear infection, especially resistant strains. 3. **Community-Acquired Pneumonia (CAP)**: Lower respiratory tract infection. 4. **Skin and Skin Structure Infections**: e.g., cellulitis, animal/human bites. 5. **Urinary Tract Infections (UTIs)**: Uncomplicated and complicated UTIs. ## Adult Dosing ### Standard Dosing **Acute Otitis Media, Acute Bacterial Sinusitis, CAP** - **Dose**: **875 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every 12 hours (BID) - **Route**: Oral - **Duration**: 10-14 days for sinusitis/AOM, 5-7 days for CAP **Skin and Skin Structure Infections, UTIs** - **Dose**: **500 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every 8 hours (TID) - **Route**: Oral - **Duration**: 7-10 days **Severe Infections or Extended-Release (ER) for specific indications (e.g., CAP, sinusitis)** - **Dose**: **2000 mg amoxicillin / 125 mg clavulanate** (ER formulation) - **Frequency**: Every 12 hours (BID) - **Route**: Oral - **Special Consideration**: Take with a meal. Do not crush or chew ER tablets. ### Dose Adjustments - **Renal Impairment**: Based on amoxicillin component. - CrCl > 30 mL/min: No adjustment needed. - CrCl 10-30 mL/min: **250-500 mg / 125 mg** every 12 hours. - CrCl < 10 mL/min: **250-500 mg / 125 mg** every 24 hours. - Hemodialysis: Administer during and at end of dialysis. - **Hepatic Impairment**: Use with caution; monitor liver function regularly. - **Elderly Patients**: Adjust dose based on renal function (often age-related decline). ## Pediatric Dosing ### Neonates (0-28 days) - **Special Notes**: Generally **not recommended** due to limited safety/efficacy data and immature renal/GI systems. Avoid if possible. ### Infants (1-12 months) - **Indication**: Acute Otitis Media, Sinusitis (moderate-severe) - **Dose**: **90 mg/kg/day** (amoxicillin component) divided - **Frequency**: Every 12 hours (BID) - **Maximum**: **600 mg** amoxicillin per dose. Max clavulanate **10 mg/kg/day**. - **Formulation**: Oral suspension (e.g., 600 mg/42.9 mg per 5mL). - **Indication**: Less severe infections - **Dose**: **45 mg/kg/day** (amoxicillin component) divided - **Frequency**: Every 12 hours (BID) - **Maximum**: **400 mg** amoxicillin per dose. Max clavulanate **10 mg/kg/day**. - **Formulation**: Oral suspension (e.g., 200 mg/28.5 mg or 400 mg/57 mg per 5mL). ### Children (1-12 years) - **Indication**: Acute Otitis Media, Sinusitis, CAP (moderate-severe) - **Dose**: **90 mg/kg/day** (amoxicillin component) divided - **Frequency**: Every 12 hours (BID) - **Maximum**: **Up to 1750 mg/day** amoxicillin (based on 875 mg BID adult dose). Max clavulanate **10 mg/kg/day or 125 mg per dose**. - **Formulation**: Oral suspension (e.g., 600 mg/42.9 mg per 5mL) or chewable/film-coated tablets based on weight. - **Indication**: Less severe infections - **Dose**: **25-45 mg/kg/day** (amoxicillin component) divided - **Frequency**: Every 12 hours (BID) or every 8 hours (TID) - **Maximum**: **Up to 1500 mg/day** amoxicillin (based on 500 mg TID adult dose). Max clavulanate **10 mg/kg/day or 125 mg per dose**. - **Formulation**: Oral suspension or chewable/film-coated tablets. ### Adolescents (13-18 years) - **Dose**: Generally follows **adult dosing** guidelines. - **Maximum**: Refer to adult maximum doses. ## Safety Information ### Contraindications - **Absolute**: History of severe hypersensitivity to beta-lactams (e.g., anaphylaxis to penicillins, cephalosporins). - **Absolute**: History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate use. - **Relative**: History of mild penicillin allergy (rash); assess risk vs. benefit. ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea (can be significant). - **Common (1-10%)**: Nausea, vomiting, rash, candidiasis (oral, vaginal). - **Serious but Rare**: Clostridioides difficile-associated diarrhea (CDAD), hepatic dysfunction (jaundice, hepatitis), allergic reactions (Stevens-Johnson syndrome, anaphylaxis), acute interstitial nephritis. ### Key Drug Interactions - **Warfarin**: Increased INR, bleeding risk. Monitor INR closely, adjust warfarin dose. - **Methotrexate**: Increased methotrexate toxicity (renal clearance reduced). Monitor methotrexate levels, adjust dose. - **Allopurinol**: Increased incidence of rash. Avoid co-administration if possible. - **Oral Contraceptives**: Potential for decreased efficacy (though evidence is debated). Counsel patients on alternative contraception. ## Monitoring & Follow-up - **Before Treatment**: Obtain thorough allergy history. If prolonged therapy or pre-existing conditions, consider baseline liver/renal function tests. - **During Treatment**: Monitor for signs of hypersensitivity (rash, fever). Assess for resolution of symptoms. Monitor for gastrointestinal tolerance. - **Clinical Signs**: Watch for persistent or severe diarrhea (C. difficile), jaundice, dark urine, or unusual bruising/bleeding. ## Clinical Pearls - 💡 **Take with food**: Administer at the start of a meal to reduce GI upset and optimize absorption. - 💡 **Refrigerate suspension**: Oral suspension must be refrigerated (2-8°C) and shaken well before each use. Discard after 10 days. - 💡 **Clavulanate ratios**: Different formulations have varying amoxicillin to clavulanate ratios. Dosing is always based on the amoxicillin component. - 💡 **High-dose for AOM**: For pediatric AOM, the **90 mg/kg/day** amoxicillin formulation (e.g., 600 mg/42.9 mg per 5 mL) is preferred for resistant S. pneumoniae. - 💡 **Complete the course**: Emphasize importance of completing the full prescribed course, even if symptoms improve, to prevent resistance. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.